Japan disasters impact Nobel Biocare financials
Nobel Biocare reported net income of $19.2 million for the first quarter of 2011, down 67% from $57 million reported in the same quarter a year ago. Revenues for the quarter were $213 million, up from $203 million for the first quarter of 2010. Nobel attributed the downturn in quarterly income to the natural disasters in Japan. The company’s Japanese business, which accounts for two-thirds of its Asia-Pacific sales, dropped

